Emergent wins $24 million BARDA contract modification
Emergent received a $24 million BARDA contract modification to supply additional doses of CYFENDUS for anthrax preparedness.
Emergent received a $24 million BARDA contract modification to supply additional doses of CYFENDUS for anthrax preparedness.Key Highlights:Original SEC Filing: Emergent BioSolutions Inc. [ EBS ] - 8-K - Sep.
01, 2026This is an AI-powered summary.
It may contain inaccuracies.
Consider verifying impo…